Dr. Luke Bucci, one of the individuals who first brought glucosamine-chondroitin combination products to market in 1991, has joined Novel Ingredient Services as its new Vice President of Product Innovation, reporting to Novel President Peter Bradley.
Dr. Bucci received his Ph.D. in biomedical sciences from the University of Texas Graduate School of Biomedical Sciences. He also holds designations as a Certified Clinical Nutritionist (CCN) and Certified Nutrition Specialist (CNS). Dr. Bucci’s expertise includes new ingredient/product assessment and development and designing research that meets manufacturers’ quality, safety and efficacy standards.
Dr. Bucci brings 30 years of experience to his new role, including his most recent position as Vice President, Research & Scientific Affairs at Renew Life Formulas. Prior to that, he spent 17 years at Reckitt Benckiser, formerly Schiff Nutrition International, as its Vice President, Research, and its Research & Scientific Affairs Specialist.
In his new role, Dr. Bucci will be responsible for identifying, developing and refining novel ingredients while taking charge of the company’s scientific clinical research efforts.
“Luke Bucci is one of our industry’s luminaries,” said Bob Green, Chairman of Novel Ingredient Services, in a press release. “With his leadership and expertise, Novel will be able to bring to market even more ingredients that offer innovation, efficacy and cost-efficiency; develop new technologies; and provide our customers with greater insight into ingredient research.”
